Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01055457 · ClinicalTrials.gov registry record · NA
Vistakon Investigational Multi-purpose Contact Lens Care Solution.
A NA study of Contact Lens Wear, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 315
- Enrollment target
- 14
- Study locations
NCT01055457: Completed NA study of Contact Lens Wear, sponsored by Johnson & Johnson Vision Care.
NCT01055457 is a NA study of Contact Lens Wear that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 315 participants, roughly in line with the 312-participant average among 3 other Contact Lens Wear trials with a reported enrollment target. The trial reports 14 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01055457, a NA study of Contact Lens Wear, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 315 participants
- Enrollment target
- 14
- Study locations
Study Summary
This study compares an investigational contact lens care multi-purpose solution to a currently marketed multi-purpose solution.
Primary Outcome
Slit Lamp Findings were assessed for each subject eye at baseline, 1-day, 1-week, 2-week, 1-month and 3-month follow-up evaluations. SLF consisted of Edema, Corneal Neovascularization, Cornela Staining, Injection, Tarsal Abnormalities and Other findings; each was graded on a 5-likert Scale (Grade: None, Grade 1: Trace, Grade 2: Mild, Grade 3: Moderate and Grade 4: Severe). The number of eyes with Grade 2 or higher across all time points for each SLF variable was reported.
Conditions Studied
Interventions
- DEVICE Vistakon Investigational Multi-Purpose Solution II
- DEVICE ReNu MultiPlus Multi-Purpose Solution
Study Locations (14)
Florida
- - Orlando
- - Tallahassee
New York
- - Jamestown
- - Vestal
Pennsylvania
- - Moon Township
- - State College
Texas
- - Amarillo
- - Katy
California
- - Mission Viejo
Illinois
- - Bloomington
Kansas
- - Pittsburg
Ohio
- - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2009-11-01 |
| Est. Completion | 2010-05-01 |
| Phase | NA |
What the finished NCT01055457 record still lists
NCT01055457 is an interventional study that assigns participants to a tested intervention. The registered 315 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 312-participant average among 3 other Contact Lens Wear trials with a reported enrollment target.
The record links to 1 condition, with Contact Lens Wear appearing as the primary indexed condition, and to 2 interventions - of which Vistakon Investigational Multi-Purpose Solution II is the first listed.
NCT01055457 lists 14 locations in 10 states (Florida, New York, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT01055457 about?
NCT01055457 is a clinical study titled "Vistakon Investigational Multi-purpose Contact Lens Care Solution.". This study compares an investigational contact lens care multi-purpose solution to a currently marketed multi-purpose solution.
What is the current status of trial NCT01055457?
This trial is currently completed. It is a NA study. The enrollment target is 315 participants. The study started on 2009-11-01. Estimated completion is 2010-05-01.
What conditions does trial NCT01055457 study?
This clinical trial studies the following conditions: Contact Lens Wear.
What interventions are being tested in trial NCT01055457?
The interventions under investigation include: Vistakon Investigational Multi-Purpose Solution II (DEVICE), ReNu MultiPlus Multi-Purpose Solution (DEVICE).
Who is sponsoring clinical trial NCT01055457?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01055457 being conducted?
This trial has 14 study locations across California, Florida, Illinois, Kansas, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contact Lens Wear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04812366 · 315 participants · Phase 2
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- NCT05101460 · 315 participants
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
- NCT05897320 · 315 participants · Phase 3
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
- NCT06439082 · 315 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI